Adimmune Corporation (TPE:4142)
Taiwan · Delayed Price · Currency is TWD 16.65
+0.05 (0.30%)
Jul 30, 2026, 12:24 PM CST
Adimmune Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,412 | 1,402 | 1,557 | 1,785 | 2,252 | 1,794 |
Revenue Growth | -10.95% | -9.99% | -12.78% | -20.72% | 25.52% | -4.03% |
Gross Profit Gross Profit Growth | 335.21 | 288.49 | 448.06 | 410.94 | 891.08 | 616.86 |
Operating Income Operating Income Growth | -293.89 | -359.55 | -298.95 | -722.75 | 93.57 | -54.09 |
Net Income Net Income Growth | -202.18 | -239.89 | -242.75 | -639.89 | 290.98 | 43.07 |
Earnings Per Share EPS Growth | -0.48 | -0.57 | -0.58 | -1.52 | 0.68 | 0.10 |
EPS Growth | - | - | - | - | 580.00% | -96.70% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Adimmune Corporation Adimmune Corporation Growth | 1,395 | 1,400 | 1,538 | 1,769 | 2,182 | 1,706 |
Enimmune Corporation Enimmune Corporation Growth | 49.95 | 48.2 | 39.92 | 43.49 | 188.42 | 109.82 |
Revenue from Internal Divisions Revenue from Internal Divisions Growth | -32.75 | -46.82 | -21.16 | -27.03 | -119.03 | -22 |
Total Total Growth | 1,412 | 1,402 | 1,557 | 1,785 | 2,252 | 1,794 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,824 | 2,218 | 2,457 | 2,470 | 2,958 | 2,891 |
Total Debt Total Debt Growth | 2,723 | 2,830 | 2,597 | 3,143 | 2,263 | 1,321 |
Net Cash (Debt) Net Cash Growth | -898.84 | -612.29 | -139.56 | -672.63 | 695.03 | 1,570 |
Net Cash Growth | - | - | - | - | -55.74% | -49.36% |
Net Cash Per Share Net Cash Per Share Growth | -2.13 | -1.45 | -0.33 | -1.60 | 1.63 | 3.66 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3.09 | -5.45 | 668.48 | -892.35 | -291.97 | -480.52 |
Capital Expenditures CapEx Growth | -194.51 | -255.16 | -231.15 | -377.8 | -419.44 | -844.09 |
Free Cash Flow Free Cash Flow Growth | -197.6 | -260.61 | 437.34 | -1,270 | -711.4 | -1,325 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 23.75% | 20.58% | 28.78% | 23.02% | 39.57% | 34.39% |
Operating Margin | -20.82% | -25.66% | -19.20% | -40.49% | 4.16% | -3.02% |
Pretax Margin | -19.47% | -23.53% | -21.61% | -43.13% | 6.94% | 0.80% |
Profit Margin | -14.32% | -17.12% | -15.59% | -35.85% | 12.92% | 2.40% |
FCF Margin | -14.00% | -18.59% | 28.09% | -71.15% | -31.60% | -73.84% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 52.18 | 445.31 |
Forward PE | - | 172.64 | 172.64 | 172.64 | 131.85 | 37.41 |
P/FCF Ratio | - | - | 19.37 | - | - | - |
PS Ratio | 4.96 | 5.70 | 5.44 | 7.83 | 6.74 | 10.69 |